Arcadia Biosciences, Inc. (RKDA) is a Energy stock trading at $0.72 (as of 2026-08-07), with a market capitalization of $1.73M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Arcadia Biosciences develops crop improvements focused on wheat and produces and markets plant-based health and wellness products in the United States. Its efforts aim to enhance crop performance in the field and the crops’ value as food ingredients, health and wellness products, and for industrial uses.
Arcadia Biosciences develops wheat-focused crop improvements and produces and markets plant-based health and wellness products in the United States, aiming to create value through better field performance, food and ingredient value, and potential industrial applications.
Its profit model depends on converting wheat crop improvement development into commercially valuable crop performance and downstream plant-based health and wellness and ingredient applications.
Business quality (Weak): The company is in a development and commercialization effort tied to crop improvements and product marketing, and it has shown a deeply negative operating margin in the latest reported period.
| Price | $0.72 |
| Market Cap | $1.73M |
| Price / Book | 2.74 |
| Price / Sales | 0.35 |
| Revenue (TTM) | $4.86M |
| Net Margin | -48.1% |
| Revenue Growth (YoY) | -3.7% |
| EPS Growth (YoY) | -66.9% |
| FCF Growth (YoY) | -50.9% |
| Altman Z-Score | -59.51 (distress) |
| Sector P/E (Energy) | 16.5 |
| Industry P/E (Petroleum & Natural Gas) | 16.3 |
| Top Institutional Holder | ARMISTICE CAPITAL, LLC ($219958.00) |
| Institutional Holders Tracked | 10 |
| Sector | Energy |
| Industry | Petroleum & Natural Gas |
| CEO | Thomas J. Schaefer |
| Employees | 9 |
| Country | US |
| IPO Date | 2015-05-15 |
Data as of 2026-08-07.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.